MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Nigrostriatal Dopaminergic Impairment Patterns in Idiopathic Normal Pressure Hydrocephalus Identified by 18F-FP-DTBZ PET: a 5-Year Longitudinal Study

C. Dong, N. Liu, JH. Ma, SY. Liu, P. Chan (Beijing, China)

Meeting: 2026 International Congress

Keywords: Dopaminergic neurons, Parkinsonism, Positron emission tomography(PET)

Category: Parkinsonism (Other)

Objective: To delineate the pattern of nigrostriatal dopaminergic dysfunction in iNPH, explore inter-individual heterogeneity, and evaluate its association with clinical features and long-term outcomes.

Background: Idiopathic normal pressure hydrocephalus (iNPH) frequently presents with parkinsonism and may exhibit dopaminergic deficits on molecular imaging. However, the specific pattern of nigrostriatal involvement and its clinical relevance remain insufficiently characterized.

Method: We enrolled 23 patients with iNPH, 29 with progressive supranuclear palsy (PSP), 23 with Parkinson’s disease (PD), and 17 healthy controls (HC). All participants underwent 18F-FP-DTBZ PET/CT scanning. Patients with iNPH received a levodopa challenge test and brain MRI evaluation. The caudate-to-posterior putamen (C/PP) ratio was calculated to stratify iNPH into two subgroups (C/PP <1 vs >1). A five-year longitudinal follow-up was conducted, with all-cause mortality as the primary outcome.

Results: In iNPH, striatal 18F-FP-DTBZ uptake was reduced compared with HC (P < 0.001). The caudate involvement was relatively prominent, whereas the anterior and posterior putamen involvement was milder than in PSP and PD. The mean C/PP ratio in iNPH was approximately 1, contrasting with values >1 in PSP and PD. Substantia nigra uptake was preserved in iNPH compared with PSP and PD, and showed no significant difference with HC (P=0.492). Based on C/PP ratio, iNPH were divided into subgroup 1 (C/PP<1) and subgroup 2 (C/PP>1). Subgroup 2 showed greater levodopa responsiveness (P = 0.009), and substantia nigra uptake showed a decreasing trend but did not reach statistical significance. During the 5-year follow-up, subgroup 2 had a higher frequency of comorbid neurodegenerative disorders compared with subgroup 1(62.5% vs 13.3%) and an earlier decline in survival probability, although the overall survival did not differ significantly between groups (log-rank P = 0.337).

Conclusion: iNPH demonstrates mild-to-moderate striatal dopaminergic impairment with predominant caudate involvement and relative preservation of the substantia nigra. A distinct iNPH subtype with prominent posterior putaminal involvement shows better levodopa responsiveness and may reflect underlying neurodegenerative comorbidity.

To cite this abstract in AMA style:

C. Dong, N. Liu, JH. Ma, SY. Liu, P. Chan. Nigrostriatal Dopaminergic Impairment Patterns in Idiopathic Normal Pressure Hydrocephalus Identified by 18F-FP-DTBZ PET: a 5-Year Longitudinal Study [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/nigrostriatal-dopaminergic-impairment-patterns-in-idiopathic-normal-pressure-hydrocephalus-identified-by-18f-fp-dtbz-pet-a-5-year-longitudinal-study/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/nigrostriatal-dopaminergic-impairment-patterns-in-idiopathic-normal-pressure-hydrocephalus-identified-by-18f-fp-dtbz-pet-a-5-year-longitudinal-study/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley